Mary Kay Barton Researchers find discordance between standard human epidermal growth factor receptor 2 (HER2) testing and HER2 status reported on Oncotype DX CA: A Cancer Journal for Clinicians 62
Article first published online: 18 JAN 2012 | DOI: 10.3322/caac.21133
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field
Choose captcha format: Image or Audio. Click here if you need help.